Latest News

LOWVELO funds are enabling Leonardo Ferreira, Ph.D., to pursue his ideas to bring cellular therapy to solid tumors for cancer treatment.

A simple test to learn about his ancestry uncovered an unexpected syndrome that increases the risk of cancer.

Hollings enrolled the first patient in a clinical trial of a new type of drug, a bifunctional antibody, for head and neck squamous cell carcinoma.

15 years after a terminal diagnosis, Nathan Calhoun is alive thanks to a clinical trial. It's why he performed at LOWVELO in 2024.

Gene therapy is being used against diseases like sickle cell and hemophilia. Could it be used against cancer?

Now more than five years out from colorectal cancer surgery, Lara Lambert is reminding everyone of the importance of screening.

MUSC Health-Charleston has achieved its third consecutive Magnet nursing designation by the ANCC.

Dr. Thomas Curran talks about advancements in colon cancer screening and why colonoscopies are still important.

When cancer runs in the family, what do you do? Two Midlands women talk about their experience and the choices they've made.

LOWVELO riders raised more than $1 million to go to cancer research at MUSC Hollings Cancer Center.

Barbara Karinshak is celebrating her cancer-free status this Colorectal Cancer Awareness Month.

After years of decreases, cervical cancer is increasing among women who live in rural areas, research at Hollings Cancer Center shows.

Breast cancer survivor Agnes Judge capped off her U.S. tour of cancer centers with a visit to Hollings, the place where she was diagnosed and treated.

Tamil Chair, Inc., has pledged $1.5 million to establish an endowed chair focused on integrative therapies in oncology.

Hollings researchers want to help older adults with head and neck cancer navigate treatment options that have mostly been studied among middle-aged adults.

MUSC Hollings Cancer Center researchers will test whether e-cigarettes are a viable quit smoking option for people who decline other options.

Lung cancer survivor Denise Swick reflects on a year of ups and downs as she went through treatment.

MUSC Health Florence brings expanded services to Pee Dee community.

MUSC's pediatric/adult bone marrow transplant program is one of 12 across the U.S. that performed better than expected, according to a new report.

MUSC Health Florence Division CEO Jay Hinesley writes from personal experience about how the Hollings Cancer Network will improve care in the Florence area.

The U.S. surgeon general is calling attention to the link between alcohol and cancer, a connection that may be news to the general public.

A new art therapy group tailored to cancer survivors is being offered this year.

Hollings researcher receives Department of Defense Early Career Scholar Award to improve immune therapies by targeting resistant kidney tumors.

MUSC Hollings Cancer Center researchers found that loosening up a CAR's grip on its Treg improved its function.

MUSC Hollings Cancer Center researcher Dr. Natalie Saini was awarded a Research Scholar Grant by the American Cancer Society.

A complicated, multidisciplinary surgery allowed a cancer survivor to leave the operating room with a full set of teeth.

When kidney cancer survivor JJ Messervy talked to a fellow patient in the waiting room, he knew he wanted to raise money for the Hollings patient support fund.

On World Pancreatic Cancer Day, researchers and survivors gathered to share progress in the fight against pancreatic cancer.

Cervical cancer deaths in women under 25, who were tweens when the HPV vaccine was introduced, have plunged, Hollings researchers show.

New research shows how Tregs could transform care for type 1 diabetes and eventually cancer and autoimmune diseases.

Family caregivers take on medical, physical, social, financial and emotional burdens. It's important to take time to care for themselves as well.

New research at Hollings shows how the Golgi body, an organelle within cells, could be a biomarker for T-cell tumor-fighting activity.

Faith and positivity - those are the things that have kept Cynthia Waddy going through the ups and downs of lung cancer treatment.

The American Cancer Society awarded Hollings researcher David Long, Ph.D., a Catalyst grant to study how two proteins' interaction affects genomic instability.

Anti-malarial drug shows promise against cancer, but resistance often develops. A Hollings team found out how, setting stage for combination therapies.

Not enough people are aware of lung cancer screening, even though the test can find early-stage, treatable cancer, Hollings researchers find.

"If you have life, you have hope," explains lung cancer survivor Juan Ramonell.

Quitting smoking soon after a cancer diagnosis adds an average of two years to a patient's life, a new study finds.

Mourning the loss of their wife and mother to astrocytoma, the Kopniskys have donated to research on brain tumors and are sponsors of LOWVELO.

A new study from MUSC Hollings Cancer Center shows how a receptor called PPAR δ helps disable the immune system so that T-cells can’t kill cancer cells.

After twice surviving cancer, an internal medicine resident feels called to oncology.

Larissa Shannon didn't want to tell people about her breast cancer - she knew she couldn't handle the 'puppy dog eyes' from her students.

Cancer patients who smoke cigarettes are more likely than nonsmokers to use cannabis, researchers find.

An artificial intelligence initiative underway at Hollings seeks to provide oncologists with insights into customized treatment options for individual patients.

Models help scientists understand how cancer develops - but researchers haven't had one for most ovarian cancers.

Diagnosed with breast cancer at only 27, Kelsey Harrison is now raising money to go toward cancer research.

Allison Hopkins Prey was overwhelmed by the support she received during breast cancer treatment – and happy to now say, two years later, it feels so long ago.

Dermatologist Graciela De Jesus, M.D., works with Hollings Hereditary Cancer Clinic patients at risk of melanoma and skin cancer.

MUSC Hollings researchers find that targeting an immunosuppressive protein on two fronts can reduce metastasis and restore sensitivity to immunotherapy.

An MUSC children’s cancer specialist and other experts from across state find 11% improvement in childhood cancer survival over 25-year period.

A newly approved targeted therapy for small cell lung cancer is at the forefront of a new type of drug for solid tumors.

Hollings was part of an international clinical trial that led to the FDA approval of a new drug to treat certain types of gliomas.

Two Hollings researchers are working together to develop a new way to get depression treatment to people with likely incurable cancer.

A new study aims to get a better understanding of what dual use of vapes and cigarettes looks like in real world usage.

Friends, family, colleagues and former patients gathered to honor Dr. Robert Stuart as a new outpatient bone marrow transplant clinic was named in his honor.

Facing a challenging journey with uterine cancer, Debra Morin made a list of five things to remember each day.

The Group 3 subtype of medulloblastoma has the worst prognosis of all the subtypes, but new research is pointing to a potential therapy.

Diagnosed with a rare uterine cancer at only 46, Lakisha Mack turned to faith, her family and her doctors.

The MUSC Hollings Cancer Center white coat ceremony inspires HBCU students to pursue research careers.

Shannon Phelps is riding in LOWVELO24 to finish her dad's aborted ride in LOWVELO23.

A new compound developed by researchers at MUSC Hollings Cancer Center shows promise in overcoming chemotherapy resistance in triple-negative breast cancer.

Too many lung cancer patients don't get all the biomarker testing they should have before beginning treatment. Dr. Adam Fox wants to change that.

The Blood and Bone Marrow Transplant team recently celebrated 3,000 transplants – and patient Kennedy Golden exemplifies why they do what they do.

A Hollings immunologist will use an American Cancer Society Research Scholar Grant to study ways to make colorectal cancer more susceptible to immunotherapy.

An MUSC Hollings Cancer Center team describes how the bacteria Porphyromonas gingivalis connects to chemotherapy resistance.

Sarah Harry may be retired but she is one busy woman: caregiving, church activities - and chemotherapy for herself.

Polyploid giant cancer cells, which are monstrously oversized and contain multiple nuclei, could be culprits in disease recurrence after cancer therapy.

A new study from Hollings researchers suggests a dual approach for targeting pancreatic cancer.

Members of the Hollings and MUSC community enthusiastically support Dragon Boat Charleston every year.

A new dedicated phase I clinical trials unit at Hollings means more and different types of clinical trials will be available to cancer patients.

A new study is the first in the U.S. to show that an available generic drug could help people stop using e-cigarettes.

After a bladder cancer diagnosis, one patient wants to raise awareness among women about this disease that can be mistaken for a UTI.

MUSC’s pipeline programs build the skills of underrepresented students and prepare them for careers in health care and medical research.

Leukogene Therapeutics Inc. introduces a promising therapy to treat multiple cancers and hopes to become flagship entity for MUSC’s innovation ecosystem.

The new Elekta Esprit Gamma Knife helps doctors to give patients with brain metastases more options.

For people with HIV, the risk of anal cancer varies significantly depending on the region of the country where they live.

A lung cancer diagnosis has focused Laura Reed's mind on how she wants to live her life.

After bladder cancer diagnosis, writer tells doctor: "I am going to live to 115. I have books to write."

After melanoma surgery, hairdresser Carol Helton is spreading the word at her hair salon about staying on top of suspicious moles.

A clinical trial of CAR-T cell therapy developed at Hollings has received NCI funding to expand.

An Ewing sarcoma researcher at MUSC is one of three scientists nationwide to receive a career development award from the Rally Foundation.

Hollings researchers use patented technology to improve immunotherapy by prolonging survival of cancer-fighting T-cells.

Hollings is a pilot site for an American Cancer Society program to train college students to navigate patients to needed resources.

Head and neck cancer surgeons at Hollings are testing a fluorescent dye that illuminates nerves, which should make them easier to find during surgery.

Through years of heartache and hard work, widower raises funds for research into the cancer that took his wife.

The National Cancer Institute renewed MUSC Hollings Cancer Center's NCI designation, awarding the center its best score ever of “outstanding performance.”

Is there a role for e-cigarettes among adults who have not been able to stop using combustible cigarettes after using FDA-approved medication?

Working with people with brain tumors brings great satisfaction to South Carolina's only neuro-oncologists.

Three MUSC occupational therapy students are passionate about elevating the profession's role in cancer care.

Two MUSC researchers think that community libraries could hold the potential to improve head and neck cancer awareness.

The South Carolina Rare Disease Council hosted a symposium that gathered rare disease researchers and advocates to chart the path forward for improved care.

South Carolinians interested in cancer survivorship - as providers, researchers, caregivers or survivors - are invited to the first SCOR symposium in June.

Meningioma doesn't attract as much research as other types of brain tumors. But Dr. Ben Strickland believes his patients deserve more options.

The annual PurpleStride walk raises money for pancreatic cancer research at Hollings Cancer Center.

Parents and providers often underestimate the fatigue that pediatric cancer patients are experiencing. An OT student created a coloring book to help.

A tobacco researcher at MUSC Hollings Cancer Center was honored by the American Society of Preventive Oncology for his work.

LOWELO23 had more riders, volunteers and dollars raised than any ride in its five-year history.

The 6th annual LOWVELO, a bike ride that raises money for lifesaving cancer research at MUSC Hollings Cancer Center, opens for registration on Friday, March 1.

An MUSC Hollings Cancer Center fellow was awarded a national grant to pursue her idea: making short helpful videos for cancer patients trying to stop smoking.

MUSC Health-Florence is one of four sites in the Southeast chosen for the Equitable Breakthroughs in Medicine Development Initiative.

Pioneering genetic screening program enrolls first 20,000 South Carolinians and provides roadmap to guide future screening efforts.

The parents of millions of teens don't intend to vaccinate them against HPV, a virus that can cause six types of cancer.

Researchers find stagnant HPV vaccine rates among young adults, though LGBTQ vaccination rates are a bright spot.

Dr. Kevin Roggin, new surgical oncology chief, says he learned how to be a well-rounded physician through good role models, and he wants to pass that along.

Breast cancer often develops resistance to previously effective drugs. Hollings researchers showed how the effectiveness of one drug might be restored.

CAR-T-cell therapy can be a powerful treatment for blood cancers, but it also has significant side effects. A clinical trial at Hollings seeks to change that.

Symposium will bring together researchers and patient advocates to inform policy and chart the way forward for patients with rare diseases.

"The Swing" presented MUSC Hollings Cancer Center with $100,000 from its breast cancer fundraising in 2023.

A decades-long downward trend in cervical cancer incidence and death rates has reversed for women in low-income areas, leading to widening health disparities.

Jian Ouyang, Ph.D., has taken on the role of director of the Translational Science Laboratory (TSL) Shared Resource at MUSC Hollings Cancer Center.

Shikhar Mehrotra, Ph.D., will take on the role of co-leader of the Cancer Biology and Immunology research program at MUSC Hollings Cancer Center.

Alex's Lemonade Stand awarded Dr. Jezabel Rodriguez Blanco a grant to research ways to prevent medulloblastoma relapse, a cancerous brain tumor in kids.

MUSC researchers have developed a training curriculum for community health workers to improve cancer genetic screening among Black women.

MUSC Hollings Cancer Center researchers show anti-cancer effects of Boswellia, from same tree that produces frankincense, in small study.

Two Hollings nurses say their involvement in the Oncology Nursing Society has helped them to grow professionally and to shape nursing practice.

MUSC Hollings Cancer Center's Dr. Hamza Hashmi helped to write guidelines for hospitals considering offering CAR-T-cell therapy on an outpatient basis.

Dr. William Hawkins is taking on the new role of deputy director of MUSC Hollings Cancer Center to strengthen the focus on translational research.

A newly approved drug to prevent neuroblastoma relapse is a huge win for patients and their families, says Jacqueline Kraveka, D.O.

As MUSC Hollings Cancer Center's 30th anniversary year comes to a close, we look back on the research and advances in cancer care that occurred in 2023.

An MUSC Hollings Cancer Center radiation oncologist is testing combining organ-sparing techniques with stereotactic ablative body radiotherapy (SABR).

A 21-day trip to Antarctica has been life-changing for one MUSC Hollings Cancer Center researcher.

A clinical trial of a new drug combination gave hope to a young woman diagnosed with tongue cancer.

Cervical cancer rates are increasing in Puerto Rico, and researchers from Hollings and the island are working together to increase screening rates.

Hollings Cafe's Jose and Wendy Perey offer food and kindness to patients and staff. Through quiet donations to Hollings, they've hit a big milestone in giving.

Knowing that past research made treatment of her salivary gland cancer possible, Michelle Brown-Nelson wanted to donate an unexpected windfall to new research.

Most people with an inherited mutation that increases cancer risk have no idea – which is why genetic testing is so important, says Dr. Kevin Hughes.

Researchers at MUSC and Cincinnati Children’s develop a novel colon organoid model with naturally occurring immune cells.

Caregiving for family members with cancer can take an emotional and physical toll. Yet few caregivers are screened for distress or connected to resources.

An MUSC Hollings Cancer Center researcher shows that SFRP2 is especially abundant in pancreatic cancer.

Susan Fasola's lung cancer was caught at an early stage, and that meant she could be treated solely with surgery - no chemo, no radiation, no drugs.

New research shows that, for the first time, there are more young people who begin to use nicotine through vaping rather than through cigarettes.

A drug that Hollings researchers were developing for cancer turns out to restore motor function in aging mice showing signs of neurodegeneration.

New program offers specialized fitness and wellness for prostate cancer survivors.

MUSC Hollings Cancer Center researchers believe that some already-approved drugs could be used in certain cases where breast cancer has become resistant.

Thai Ho, M.D., Ph.D., will lead precision oncology efforts at MUSC Hollings Cancer Center.

Even oncology nurses don’t look forward to certain cancer screenings. But everything is better with a friend – even colonoscopies.

Dana Booker's complex breast cancer case required multi-disciplinary care – and doctors who understood that getting to a concert was important, too.

Dr. David Burns, an expert witness in cigarette industry lawsuits and editor of surgeon general reports, will speak at the 2nd annual Rosenblatt Lectureship.

An increase in cervical cancer deaths in Appalachian Kentucky could point to hidden issues in other regions of persistent poverty.

A clinical trial at MUSC Hollings Cancer Center is testing a shorter course of radiation therapy for sarcoma patients to ease the logistics of getting care.

October will always be more than Breast Cancer Awareness Month for this breast cancer survivor. It's now her wedding anniversary month.

Kathryn Diamond felt hopeless when she realized she had breast cancer. But then she learned how much treatments have changed.

Surveys at 12 cancer centers across the U.S. looked at cannabis usage among cancer patients.

The average age of this LOWVELO fundraising team? Somewhere between 80 and 90. Residents of South Bay at Mount Pleasant are walking and swimming for a cause.

Doctors with MUSC Hollings Cancer Center are the first in South Carolina to perform head and neck cancer surgery with the single port da Vinci SP.

As people with HIV live longer, they are more likely to get cancers that come with age but HIV might complicate treatment.

Local doctors combine community cancer care with access to research through Hollings NCORP-MU.

Scientists at MUSC Hollings Cancer Center think it's possible that CAR-T-cell therapy could be performed without lymphodepleting chemotherapy beforehand.

A new method to study changes in sugars coating immune cells could potentially identify novel biomarkers and detect cancer earlier.

Three Hollings members – an M.D., a D.D.S. and a Ph.D. – are pooling their expertise to develop a personalized vaccine to prevent oral cancer from returning.

MUSC Hollings Cancer Center awarded a number of pilot grants through the spring and summer to kickstart research projects on a range of topics.

The Clinical Trialist Training Program offers early-career clinicians the time and know-how to lead clinical trials.

The role of e-cigarettes is hotly debated. A new study shows they could have a role in helping adult smokers to quit.

Hollings works with more than a dozen sites in South Carolina to bring clinical trials to the community, including the Ralph H. Johnson VA Health Care System.

MUSC Hollings Cancer Center is leading a national trial to test an intervention to get more head-and-neck cancer patients to radiation therapy on time.

Dr. Benjamin Toll, director of the Tobacco Treatment Program, has been dismayed that so many misunderstand the continuum of risk for tobacco products.

Andy Abrams likes to say he’s the poster child for routine cancer screenings. In his case, one screening led to the diagnosis and treatment of two cancers.

Almost 25 years ago Pat Coyne visited Tanzania to help with a pain management problem. Four decades – and dozens of countries – later, he's still at it.

Hollings researcher Sophie Paczesny led a multicenter team to identify risk biomarkers of chronic graft-versus-host disease.

Hollings director Dr. Raymond N. DuBois has been honored as a fellow of the Royal College of Physicians.

Bare minimum reimbursement rates could be a factor in why some clinics may be struggling to offer HPV vaccination in the U.S.

Students from four Charleston County high schools spent their summer learning how to research in labs at MUSC Hollings Cancer Center.

Prostate cancer survivor shares his story to encourage other men to know their options and take action.

A team of researchers uncovered the structure of a 'hidden pocket' on a KRAS mutation that could enable developing next-generation inhibitors.

Smoking cessation counselors at Hollings focus on the positive changes their clients are making, providing nurturing support and evidence-based strategies.

MUSC Hollings Cancer Center researchers find that autologous stem cell transplant for multiple myeloma is usually safe as outpatient procedure.

If a first try at quitting smoking doesn't work, should the same method be tried again? Or a new method? Hollings researchers are seeking answers.

"It's been an experience," is Susan Shelton's understated way of explaining her journey with oral cancer.

A Hollings researcher's startup got a Small Business Technology Transfer grant to develop triple negative breast cancer findings into a potential drug.

MUSC Hollings Cancer Center researcher Benjamin Toll, Ph.D., is excited and hopeful about the Cancer Moonshot's focus on smoking cessation.

MUSC team finds a new, more specific biomarker for a liver cancer type. Currently, no specific diagnostic tools of this type exist for this disease.

Will remote trials overcome the barriers that make it difficult for underserved populations to participate in clinical trials? A Hollings researcher weighs in.

Carol Sullivan was stunned to learn she had ovarian cancer. She decided to pursue aggressive medical options - and to consciously maintain a positive mindset.

A Hollings researcher wants to ID risk biomarkers to enable doctors to stop a serious side effect of stem cell transplant before it happens.

A new water component of the Survivors' Fit Club for breast cancer survivors has one group of women calling themselves 'the mermaids.'

An MUSC Hollings Cancer Center doctor is leading a national trial to test whether drugs used after large B-cell lymphoma returns could instead prevent relapse.

A specialized chemotherapy treatment allowed a retired art teacher to continue with her love of painting, despite a rare cancer diagnosis.

CAR-T-cell therapy has given one lymphoma survivor another chance to see the world with his wife.

MUSC initiative aims to increase human papillomavirus vaccination rates in underserved communities.

A special course on topics in cancer research for undergraduates at SC State University culminated in a tour at MUSC Hollings Cancer Center.

How might allowing flavored e-cigarettes or banning menthol cigarettes affect people's tobacco use? The FDA wants a Hollings researcher to find out.

He made a promise to his niece. He was going to ride 100 miles in LOWVELO and nothing was going to stop him.

An MUSC Hollings Cancer Center team ID'd a protein that helps cancer cells to navigate the cell division process despite an abnormality that should doom them.

After esophageal cancer treatment, Huger man is grateful for time with his family.

Dr. Michael Cummings was honored for the groundbreaking advances he's made over a 40-year career in tobacco control research.

Debbie Grenier dreaded surgery. She still has major scars from a surgery 45 years ago. So she was astonished at her experience undergoing robotic lung surgery.

Two small business grants will help Hollings researchers to test new ways to treat acute myeloid leukemia.

An expanded clinic space will facilitate even more collaborative multidisciplinary care from the head and neck cancer team.

Dr. Hamza Hashmi hopes an immunotherapy drug in clinical trials will one day lead to a cancer cure. For now, it's enough to help one woman lead a normal life.

LOWVELO23, raising money for cancer research at MUSC Hollings Cancer Center, is gearing up for its fifth year.

How a traffic stop led to saving Tamara Palmer's life.

Adult and pediatric doctors pooled their expertise to ensure a young patient would have few physical reminders of an extraordinary lung cancer surgery.

For Hannah Neimy, there's no better place to learn to be a doctor than the place where she was treated for Hodgkin lymphoma.

Using the power of bioinformatics, GI scientists turned cancer researchers find that elevated levels of molecular motor Myo5b are implicated in uterine cancer.

In retrospect, Adriel Nutter sees that she was sick long before her colorectal cancer diagnosis. But as a young adult, this cancer wasn't on her radar.

No one thought Ebony Holmes' symptoms could be cancer. Unfortunately, she's part of the trend of younger adults being diagnosed with colon cancer.

Aron Kuch honored his wife, Heather's, memory by riding in LOWVELO to raise money for cancer research.

An MUSC Hollings Cancer Center team has created what members believe to be among the first small molecules designed to stimulate immune cells to fight cancer.

An MUSC Hollings Cancer Center doctor is one of only 12 chosen to participate in the National Cancer Institute’s Early-stage Surgeon Scientist Program.

Three of this year's TEDxCharleston speakers work for MUSC.

891 riders and 105 teams raised more than $433,000 to make LOWVELO22 the biggest yet.

MUSC Hollings Cancer Center is investing in its scientists' research, providing pilot grants to help projects to get started.

A recent statement by an ovarian cancer advocacy group is raising awareness about the option to remove the fallopian tubes.

From the operating room to the board room, we take a behind-the-scenes look at the life of MUSC President Dr. David Cole.

A Stand Up 2 Cancer grant will help to ensure that Fetter Health Care patients at risk of lung cancer get the screenings they need.

Patient relationships drew surgeon to head and neck cancer care; improving care keeps her motivated.

A type of cell that plays a key role in pancreatic cancer can trace its origin back to a structure that forms during embryonic development.

MUSC Hollings Cancer Center’s Benjamin Toll, Ph.D., is thrilled to be elected to help lead the Society for Research on Nicotine & Tobacco.

Hollings Cancer Center director Raymond N. DuBois, M.D., Ph.D., honored two of the center’s up-and-coming researchers with the High Impact Publications Award.

Emily Bott didn't plan to ride in LOWVELO. But when her mom was diagnosed with breast cancer, she wanted a way to contribute to cancer research.

A casual brainstorming session led Hollings researchers to consider how two systems within the body might be "talking" - and enabling cancers to grow.

Playing “serious” games can be an effective and engaging way to teach teamwork and other skills to robotic surgery teams.

With almost 20 years in clinical trials under her belt, Shanta Salzer loves that she can help patients and advance cancer research.

Head and neck cancer survivors often deal with body-image distress. A new cognitive behavioral therapy focused on their unique needs looks promising.

Although their immune systems have trouble producing antibodies on their own, a monoclonal antibody protected blood cancer patients from severe COVID.

The average lung cancer patient is a 71-year-old man. Kelly Bulak was far from the average. Her parents are still grappling with her death from this disease.

Medical University of South Carolina researchers show how DNA is packed away when it needs to be turned off.

MUSC researchers develop a new inhibitor and test its effects when used together with an existing anti-cancer therapy in neuroblastoma

MUSC honors employees who have reached milestones in their service.

Clinical trials coordinator Alexandria Green falls in love with all her patients. But she's formed a particularly strong bond with one in particular.

A protein that is normally thought of as controlling transcription is actually holding down two jobs, researchers at MUSC Hollings Cancer Center found.

South Carolina is seeing one of the fastest rises in anal cancer incidence among women and anal cancer mortality among men.

For lung cancer screening to work, people need to get scans every year. But a new study shows people don't return for repeat scans.

Science and faith: The Hardys have survived two cancer diagnoses thanks to clinical trials and support from faith, family and friends.

After years of decline in cervical cancer rates, one group of women is now seeing an unexpected increase.

Lung cancer doesn't show signs when it's small and most treatable. That's why Hollings encourages screening for lung cancer instead of waiting for symptoms.

People in rural areas are more likely to smoke and less likely to quit. A Hollings psychologist is using e-visits to reach these smokers and help them to quit.

Riding 100 miles to raise money for cancer required persistence - just like doing research in the lab, says Dr. Leo Ferreira.

Everything came together to make LOWVELO22, raising funds for cancer research at Hollings, a resounding success.

Lung cancer screening sites across the country are opening on Saturday, Nov. 12, to increase awareness of this option to find cancer early.

All the advances in cancer care don't help if people can't get to appointments. A paper lays out the issue of transportation insecurity for people with cancer.

Hollings offers hard-to-find therapy for rare T-cell cutaneous lymphoma.

A breast cancer survivor found a special connection with a mammography tech who could truly say "I've been in your shoes."

Triple negative breast cancer has been a life-changing adventure for Joannah Sampson, and now she wants to give back.

'Nice guy' researcher's pioneering colon cancer work could have implications for other cancers.

Aleasa Barry has a simple message – knowing you have cancer isn't half as scary as not knowing because you won't get screened.

After losing a son to cancer, the Eaton family is carrying on his idea to donate iPads to cancer centers for patients to use.

Unique collaboration builds equity into the fabric of care and research at MUSC.

After battling cancer twice, Danielle Lee says she's a 'walking miracle.'

Joshua Kim has a gift for finding areas of health care that could use improving and then just making it happen.

Dr. Jon Samet, an expert on secondhand smoke, will review how we "bent the curve" on smoking in the U.S.

Doctors at MUSC Hollings Cancer Center say that colonoscopies remain an important screening tool, question results of recent study.

A Hollings immunologist is investigating how a protein might alter a person's immune response and gut microbiome, contributing to colon cancer.

After losing her mother to cancer, a young woman determined to make a career in science.

An annual lung scan caught cancer early for one - now former - smoker.

Breast cancer researcher develops new drug candidates, nearing clinical trials.

For the past seven years, MUSC has held its annual Blessing of the Therapy Dogs. The event is a chance to say thanks to its volunteers, both human and canine.

Hollings researcher Joe Delaney is one of 72 recipients of the NIH director’s New Innovator Award, which funds unusually creative early-stage investigators.

Screening mammograms are now available at the West Ashley Medical Pavilion, with more breast care services to come.

MUSC Hollings Cancer Center is promoting entrepreneurship among its researchers.

Ashish Deshmukh, Ph.D., was drawn to the Cancer Control program at Hollings by its collaborative spirit.

A pilot study will measure circulating tumor DNA in cancer patients with 'extraordinary' response to immunotherapy.

Proper pain management allowed Julie Jablin, who has stage 4 lung cancer, to attend a wedding overseas and enjoy everyday life.

With a grant from The Duke Endowment, a new project at MUSC Hollings Cancer Center has ambitious goals to increase screening rates for five cancers.

Matt Miller never expected to fight cancer so soon after his mom did. Now, his band is headlining the LOWVELO finish-line block party.

A Hollings researcher has received two grants aimed at early career investigators to help advance his breast cancer research.

A new MUSC Hollings Cancer Center patient support group focused on head and neck cancer patients launches this month.

A summer in a research lab might change one Charleston County high schooler's career path.

Consider "place, space and ancestry" when investigating health disparities, said the keynote speaker at a cancer health equity symposium at Hollings.

Peggi Angel, Ph.D., is looking at whether glycosylation regulation may be influenced by socioeconomic stressors and contribute to breast cancer disparities.

An MUSC Hollings Cancer Center researcher is among the first to use a new device meant to improve Treg gene editing.

Two nurses on the inpatient unit of MUSC Hollings Cancer Center have been honored for their work with the Palmetto Gold.

A national study is assessing whether online courses on pain management can help cancer patients.

A clinical trial at MUSC Hollings Cancer Center will investigate if a common statin could lead to a stronger anti-tumor response in prostate cancer patients.

MUSC student Valerie Salmon, 22, lost both her parents to cancer. She's riding in LOWVELO22 to fund research so fewer people will experience such loss.

Early career researcher at Hollings awarded grant by Pancreatic Cancer Action Network.

Jezabel R. Blanco is determined to find better treatments for children with medulloblastoma.

A dozen undergrads, mostly from historically Black colleges, are spending the summer concentrating on cancer research at MUSC Hollings Cancer Center.

Hollings researchers are testing combinations of drugs used for conditions including HIV and diabetes to instead fight cancer.

Charleston police chief Luther Reynolds believes in living with purpose – especially after losing a leg to cancer.

OT student leads LOWVELO bike team after successful thyroid cancer treatment at MUSC Hollings Cancer Center.

Vaccine guru Dr. Danielle Scheurer helps make sense of boosters, random health care charges and everything else weighing on our minds as summer hits full stride

Hollings and the Charleston Ocean Racing Association will host the MUSC Hollings Cup Regatta in Charleston Harbor to raise funds for lifesaving cancer research.

The children's cancer team attained the best outcomes in the Southeast, according to recently released rankings.

Patient Marty Perlmutter says the CAR-T-cell therapy he received for cancer is like science fiction has become reality.

Hollings offers cancer patients relief with variety of pain procedures.

Pain is one of the top fears of cancer patients. Dr. Thor Johnson wants to relieve those fears.

A new initiative at MUSC Hollings Cancer Center aims to improve survivorship care for cancer patients.

Nicholas Shungu will lead efforts to ensure that diversity, equity and inclusion remain at the forefront of Hollings Cancer Center's work.

After surviving testicular cancer, Michael Wiegand uses humor to raise awareness and money for research.

A new joint program at MUSC and Clemson University will offer training in how to harness big data to identify and address health inequities.

Kimberley Trump had tried over the years to quit smoking. With the help of the MUSC Tobacco Treatment Program, she thinks she's finally succeeded.

A Hollings researcher is investigating how yogic breathing may help cancer patients’ quality of life and health.

A clinical trial gave one melanoma patient access to cutting-edge treatment before the medication came to market.

Doctor offers advice to prevent or treat sun damage.

"Safety is no accident" is a motto wholeheartedly embraced by the Radiation Oncology team at MUSC Hollings Cancer Center, which has earned reaccreditation.

It takes a special breed to become a nurse. But to be one for more than 25 years? That take a monumental level of devotion and compassion.

Every year artificial intelligence becomes more intertwined with health care. Some of the areas top AI minds got together to discuss how to take it further.

Dr. Greer Albergotti is driven by a multidisciplinary patient-centered approach to treating head and neck cancer patients.

Originally trained as an engineer, Dr. Robert Labadie brings a different perspective to the Hollings head and neck cancer team.

Dr. Jason Newman brings passion, expertise and big ideas to his new role leading head and neck oncology at Hollings.

Dr. Raymond N. DuBois received the Distinguished Service Award during the opening ceremony of the 2022 AACR convention.

Dr. Shikhar Mehrotra's team has found a new approach that shows promise of boosting the long-term success of T-cell therapy.

MUSC researchers have developed a way to remove toxic chemotherapeutic drugs from the blood after cancer treatment to prevent them from reaching the heart.

Dr. Angela Yoon brings her expertise on biomarkers and immunotherapy to the Hollings head and neck cancer team.

Dr. Bhisham Chera hopes to offer head and neck cancer patients at Hollings less toxic and more effective treatment options.

Dr. Kevin Hughes leads Hollings' Hereditary Cancer Clinic, one of first in nation.

Expansion allows more to participate in community research program In Our DNA SC.

A Hollings researcher helped develop a new program to increase smoking cessation efforts in 1,500 national cancer centers.

Hollings researcher Leonardo Ferreira, Ph.D., is driven by the passion to make chimeric antigen receptor (CAR)-T-cell therapies safer and more widely available.

A Hollings clinical trial for HPV-related head and neck cancer is showing promising results.

If you don’t know the signs and symptoms of multiple myeloma, you’re a part of Tiffany Williams' mission in life.

Hollings received its first Stand Up to Cancer grant that will make it part of a group addressing lung cancer disparities.

Researchers aim to use social media to increase HPV vaccination rates in South Carolina.

Glenn Bachmann is helping to move the science forward by participating in a clinical trial at Hollings in the hopes of helping other patients.

LOWVELO22 opens registration March 14, with expectations that the fourth year will be even bigger and better than ever.

LOWVELO21's top fundraiser, Jenny McKay, shares her tips for other participants as LOWVELO22 ramps up.

Hollings is rolling out a new physical therapy program specifically tailored to cancer patients and survivors.

MUSC Hollings Cancer Center is hosting a new training to increase the number of tobacco treatment specialists in South Carolina.

Hollings' growing genetic counseling team helps patients understand their cancer risk and preventative steps they should take.

An MUSC Hollings Cancer Center study sheds light on better ways to prevent and treat colorectal cancer.

Hollings researcher Dr. Steven Rosenzweig's accidental lab discovery led to an amazing finding that he will present at the TEDxCharleston event.

Hollings researcher Sophie Paczesny, M.D., Ph.D., received a grant to help doctors to fight complications after pediatric bone marrow transplantation.

Making small lifestyle changes can have a big impact on cancer risk and outcome.

Hollings researcher John O’Bryan, Ph.D., and colleagues have demonstrated a new therapeutic way to block a protein that is frequently mutated in cancers.

Vance Kennedy loves to sing. Despite battling cancer twice, he hasn't missed a beat.

The HPV vaccine helps to prevent six HPV-related cancers. With Hollings' HPV vaccination van, the vaccine will be taken to medically underserved counties.

This week Dr. Danielle Scheurer talks about what masks are best for you as well as just how easy it is to get tested for COVID these days.

After battling cervical cancer, Mikiko Dollard is inspiring others with her story - including her own daughter.

Hollings researcher Sophie Paczesny, M.D., Ph.D., received a $628,188 grant from the National Cancer Institute to improve graft-versus-host disease treatment.

Four Hollings researchers received grants from the American Cancer Society to support their work on promising projects.

After battling prostate cancer twice, Friedrich Andreas is sharing his story with others in hopes of raising awareness.

Percentages are for the cool kids these days. We talk with Dr. Danielle Scheurer about all-things COVID.

Newly approved treatments and more cervical cancer clinical trials on the horizon have Hollings doctors optimistic.

More than $1.8 million was raised for the Medical University of South Carolina as a part of Giving Tuesday.

The collaborative biorepository project between MUSC and SCSU is expanding with the hopes of reaching more medically underserved communities.

On Friday, the Therapy Dog Howliday Parade brought smiles (and sniffs) to patients, families and staff at MUSC’s downtown campus.

When navigating a cancer diagnosis during the holidays, Wendy Balliet, Ph.D., likes to give her patients a piece of advice – stay present in the moment.

Out of more than 60 teams from across the state, two from MUSC were awarded the top prizes in the inaugural S.C. Innovates Student Pitch competition.

Gladys Cano was overwhelmed with emotion as she rang the bell inside of Hollings' infusion suite to mark the end of treatment.

The holidays can be a tough time for cancer patients and caregivers, particularly for those who are enduring a losing battle.

Hollings researchers are part of a new global study that will examine different regulatory approaches to tobacco products.

Most people battling cancer don’t give a second thought to the clothes they wear to treatments. Jim Nelson isn’t most people.

A Hollings researcher attended the first U.K.-U.S. scientific summit with more than 60 other leading cancer research experts.

A new study estimates that over 5,000 cancer deaths were prevented in early Medicaid expansion states during the study period.

State funds make up less than 4% of MUSC’s annual budget. That’s why Giving Tuesday is so important to MUSC.

Hollings kicked off Pancreatic Cancer Awareness month with a balloon walk marking the start of an exciting week for PanCAN SC.

Boosted by his success in beating alcoholism 15 years ago, Bob Hessler was determined to defeat his pancreatic cancer too.

Hollings researcher Dr. Leonardo Ferreira is exploring ways to use regulatory T-cells to treat a range of autoimmune problems.

Researchers found that Black men in a study didn’t feel as though they had adequate information about prostate cancer screenings.

A new study finds that the recent changes to lung cancer screening guidelines may increase health disparities, not reduce them.

A diagnosis of stage 3 anaplastic astrocytoma started a decade-long friendship with this cancer patient and his infusion nurses.

Motivated by strong bonds with his patients, Dr. Evan Graboyes joined the Riding for Rayna team for the LOWVELO21 bike ride.

The Canadian Partnership Against Cancer reports that it’s increased the number of smoking cessation services in Canada to 87%.

Participants braved the cold and wind to celebrate LOWVELO21 and its cause: raising money for cancer research at Hollings.

LOWVELO ambassador Karen “KJ” Luther now advises others on healthy lifestyle choices after her own dramatic weight loss.

After a cancer diagnosis, LOWVELO rider Bruce Dales turned to running and cycling groups to become more active and healthy.

The new mobile health unit will travel to rural and underserved communities and offer breast and cervical cancer screenings.

Lana Kammer, an endometrial and breast cancer survivor, credits her daily walking routine for helping during cancer treatment.

First lady Dr. Jill Biden promotes health equity and breast cancer awareness during a visit to MUSC Hollings Cancer Center.

Hollings is offering breast cancer patients more reconstructive options thanks to technology and advanced surgical techniques.

Oral-cavity squamous cell carcinoma, a subset of head and neck cancer, is prevalent in South Carolina due to the history of tobacco use.

The TMIST trial will provide insights into which type of screening is best and how to improve future breast cancer patient care.

Hollings rolled out a new mini-mobile health van to make it easier for parents to get their children HPV vaccinated.

Dales will join the other 700 participants for LOWVELO saying the ride gives him a chance to connect with other cancer survivors.

MUSC Hollings researchers were recently awarded a $9.7M grant by the NCI to study excessive weight loss caused by cancer.

This mom couldn’t have imagined her toughest battle wouldn’t be in the military. It was fighting stage 4 terminal lung cancer.

Drs. David Turner and Victoria Findlay secured a $228K grant to find if advanced glycation end products in pet food cause cancer.

Dr. Rana Pullatt is leading the way at MUSC Health for robotic surgical procedures. The surgeon believes it is the future of medicine.

Hollings researcher Dr. Haizhen (Jen) Wang was awarded a $344K per year grant by NCI for her studies in leukemia.

MUSC Hollings researcher Graham Warren received a prestigious lectureship award for Tobacco Control and Smoking Cessation.

Varnesta Major is celebrating the upcoming holidays with family one year after being diagnosed with stage 2A breast cancer.

The breast cancer support group meetings provide a resource for patients at any stage of treatment to connect with others.

During cycling classes, Ja’Net Bishop heard about LOWVELO, an annual event that raises money for cancer research at Hollings.

Hollings researchers Dr. Wenjian Gan and Dr. Tracy Smith are the first winners of Hollings' High Impact Publications Award.

Hollings combines expert research and state-of-the-art treatments to offer prostate cancer patients the best possible care.

Hollings launches a new prevention and awareness program to reduce prostate cancer deaths among Black men in South Carolina.

Hollings is part of a prestigious national grant that will address lung cancer disparities using a collaborative approach.

Hollings researchers use imaging technology to identify liver cancer subtypes based on the sugar structures on tumors.

Hollings researchers are studying the rise of colorectal cancer in young people and why minorities are more vulnerable.

According to a new population-based study, researchers attributed over 700K new cases of cancer in 2020 to alcohol consumption.

Hollings director appointed to international working group dedicated to supporting cancer prevention research.

Hollings taking part in study to improve the delivery of patient-centered care for head and neck cancer survivors.

LaToya Wilson’s cancer journey began in 2012 when she noticed a walnut-size lump in her right breast after giving birth.

Hollings researcher Dr. Michael Cummings won a prestigious award for his major contributions connecting smoking and disease.

Hollings researchers found a mechanism showing how gene mutations allow tumors to evade detection in colorectal cancer patients.

Hollings researchers received a grant from the DoD to investigate how dietary fat affects the development of colon cancer.

Everyday Everest founder Cokie Cox summited Mount Everest, raising critical funding for cancer research at MUSC Hollings.

MUSC Hollings will glow blue the week of Aug. 30 at the start of LOWVELO’s Glow Blue Week to celebrate the LOWVELO 2021 ride.

Scans revealed the presence of infiltrates, a lung scan’s hazy gray area, serves as a marker of COVID-19 prior to symptoms.

With COVID variants spreading quickly, health experts urge cancer patients and families to take caution with rising numbers.

Diversity in clinical trials makes medicine safe for everyone.

Measuring circulating blood levels of a specific lipid, allows clinicians to predict whether COVID-19-positive patients will develop symptoms.

This former pro basketball player now puts the crossover on cancer as a tobacco treatment specialist in the PeeDee region.

A bench-to-bedside-pioneered lung cancer immunotherapy developed at MUSC Hollings to be offered in NCI clinical trials.

MUSC Hollings Cancer Center hopes to save lives by expanding the Tobacco Treatment program to rural, underserved communities.

MUSC Hollings Cancer Center will receive $39K following a landmark enforcement action against four fraudulent cancer charities.

Brian Hess, M.D., a Hollings researcher and lymphoma specialist, was key in bringing a lymphoma clinical trial to Hollings.

Cancer survivor Jana Chanthabane turns tragedy into triumph while raising money for cancer research in Swim Across America.

Immigrants bring fresh perspectives that enrich cultural, intellectual and scientific pursuits but often face obstacles.

Hollings researchers are studying how a new medicine could give blood cancer patients a better shot at remission.

Black individuals of African ancestry are approximately 30% of S.C.’s population and are disproportionately affected by HNC.

Tropical Storm Elsa is expected to bring heavy rainfall to Georgia and the Carolinas, which means MUSC emergency preparedness experts are at the ready.

The FDA is moving to ban menthol cigarettes and flavored cigars in the U.S. and sparking hope for smoking cessation advocates.

A routine mammogram detected something that no one can truly prepare for – stage 1 breast cancer in her right breast.

Nationwide, skin cancer is the most common cancer. In South Carolina, skin melanoma is the 5th most common cancer diagnosed.

According to Dr. Jerry Squires, medical director of Transfusion Services at MUSC, our country has never been in a worse predicament, blood donation-wise.

Retiring Hollings oncologist Dr. Robert Stuart received the Order of the Palmetto, South Carolina's highest civilian honor.

Charleston-born musician Darius Rucker threw a concert for front-line workers, and it was the closest thing we've seen to normal in a long time.

Demand for genetic testing has risen 422% in the last year and can determine if you’re at risk of developing other cancers.

A beloved doctor and mentor, Hollings oncologist Dr. Robert Stuart is retiring after working for more than 30 years at MUSC.

Personal loss inspired a Hollings researcher to apply breast cancer findings toward a potential new osteosarcoma treatment.

For patients running out of treatment options, new CAR-T-cell therapy at Hollings offers another shot at remission.

MUSC Hollings Cancer Center researchers have secured important funding for trials to reduce vaping among adolescents.

A multidisciplinary Hollings team is collaborating on a project to make CAR-T-cell therapy safer and more effective.

Robert Conley overcame the removal of multiple organs, including part of his stomach, to be ready to ride in LOWVELO 2021.

Dr. Besim Ogretmen and his research team found a new link between aging, metabolism and anti-cancer T-cell function.

Hollings researcher Dr. Jen Wang was awarded a $225,000 Young Investigator grant from the Melanoma Research Alliance.

Dr. Craig Lockhart shares his background and future vision for Hollings as he begins three clinical leadership roles at MUSC.

MUSC neurologists are the first to develop a preclinical brain cancer model using cutting-edge BrainPath technology.

Hollings researchers have discovered a more efficient way to enhance gene silencing for potential use in cancer drugs.

The SC AMEN Program at Hollings is an innovative and timely approach to address prostate cancer disparities among Black men.

Hollings is part of a national call to action to get HPV vaccination back on track for children and adolescents.

Hollings researcher finds that older Medicare beneficiaries have better lung cancer outcomes than younger uninsured patients.

After previous bouts with cancer, 85-year-old Navy veteran Wil Doak didn't let multiple myeloma knock him off course.

New mom Liza Patterson describes her painful struggles with anxiety and guilt following a successful battle with lymphoma.

Hollings researchers find that asymptomatic individuals had stronger antibody responses to COVID-19 versus symptomatic patients.

Roughly 40% to 50% of people with HIV smoke, so Hollings researchers are studying ways to improve tobacco treatment delivery.

Hollings is enrolling patients in a national clinical trial to compare radiation therapy treatments for prostate cancer.

This week Dr. Scheurer talks about how switching strategies is the key to overcoming vaccine hesitancy.

Researchers at Hollings are collaborating on a project to expand lung cancer screening and treatment options for veterans.

This week, Dr. Scheurer answers questions about air travel, vaccine hesitancy and surges.

The rectal cancer program at Hollings has earned accreditation from the National Accreditation Program for Rectal Cancer.

Technology developed by Hollings researchers can detect early-stage liver cancer at double the rate of current tools.

A new study by Hollings researchers shows that more than 60% of U.S. adults who vape are interested in quitting.

Cokie Cox's Mount Everest climb is generating awareness and funding for cancer prevention and outreach at Hollings.

Experts at Hollings and MUSC Health addressed a range of topics surrounding COVID-19 vaccination and cancer patients.

Registration opens March 24 for LOWVELO, Hollings' annual bike ride to raise money for lifesaving cancer research.

The first annual LOWVELO Symposium will focus on building a successful career in cancer research for trainees at all levels.

Hollings is partnering with the Talbot family to bring a state affiliate of the Pancreatic Cancer Action Network to South Carolina.

How do viruses mutate? How do vaccines keep up? Dr. Danielle Scheurer explains in this week's Q&A.

Dr. Danielle Scheurer talks about hugging, sequencing and variants in this week's COVID vaccine Q&A.

Dr. Thomas Curran discusses colorectal cancer screening options, which are now recommended for average-risk patients at age 45.

Rectal cancer survivor and ER physician Lara Lambert encourages others to get screened and know the signs and symptoms.

With the weather starting to warm up, it’s fitting that vaccines are following suit.

This week Dr. Danielle Scheurer talks about ways to incentivize people to get vaccinated.

Hollings researchers aim to generate awareness about lung cancer screening disparities in order to improve treatment outcomes.

The Hollings lung cancer screening program aims to increase access to screenings and promote the benefits of early detection.

Hollings dietitian offers tips on maintaining a healthy diet and navigating eating challenges that arise during cancer treatment.

Hollings will host a virtual panel discussion and Q&A session on March 4 about COVID-19 vaccination for cancer patients.

State officials, drug companies and vaccinators might be starting to hit their stride.

A new paper published by Hollings researchers reveals a potential new approach for reducing graft-versus-host disease.

Hollings researchers discovered that a single strain of bacteria significantly reduced graft-versus-host disease.

A nationwide study hopes to gain insight about COVID-19 in cancer patients and how treatment outcomes are affected.

Patrick Flume, M.D., who leads the new Novavax and Janssen vaccine trials, answers questions that potential participants might have.

A brain cancer diagnosis gave Claudia Salazar even more motivation to make an impact in cancer research and health disparities.

MUSC leadership previewed OneMUSC, the new roadmap that will guide the vision for every individual at MUSC.

Dr. Craig Lockhart joins MUSC as the new chief of Hematology & Oncology and the associate director for clinical science at Hollings.

After multiple opinions and hospital visits, Halea Wylie finally found the cervical cancer treatment she needed at Hollings.

A Hollings clinical trial is testing the impact of changing the order of treatments for metastatic prostate cancer patients.

Dr. Elizabeth Hill has joined MUSC Hollings Cancer Center as the new director of the Biostatistics Shared Resource.

A portion of the proceeds from this year's Head for the Cure Charleston 5K will support brain cancer research at Hollings.

Marine veteran Tony Pesavento survived multiple battles with larynx cancer and credits a clinical trial with saving his life.

Hollings researchers are testing a new prostate cancer drug that may help patients who stop responding to standard treatments.

In honor of Cervical Cancer Awareness Month, Dr. Jerlinda Ross shares what she wishes more women knew about cervical cancer.

Even during the pandemic, getting routine cancer screenings is important because early detection is key to better treatment outcomes.

Hollings experts offer six tips for adopting lifestyle changes that can help lower your cancer risk and improve your health.

It turns out vials of the Pfizer-BioNTech COVID-19 vaccine – each of which was supposed to contain five doses – has as many as one or two more in them.

MUSC received its first shipment of the Pfizer COVID-19 vaccine on Tuesday. In less than three hours of receipt it was going in the arms of front line workers.

MUSC will receive its first wave of COVID-19 vaccines from Pfizer the week of Dec. 14.

When diagnosed with leukemia, MUSC Health-Charleston CEO David Zaas benefited from a clinical trial. He wants all MUSC patients to have the same opportunity.

Hollings head and neck cancer experts team with international collaborators to offer practical tips for clinicians.

New smoking cessation training program offers tools for health care providers to support patients through their cancer journeys.

Dr. Nancy Klauber-DeMore receives notable distinction for her academic innovation in cancer research and impact on patients.

Hollings researchers study how, why, and how often patients use marijuana to relieve cancer symptoms and side effects.

MUSC Health's 3,295 square-foot high risk infectious disease unit is the only state-designated Ebola Treatment Center.

On the cusp of starting grad school, Kelly Bulak found herself facing an unexpected battle with lung cancer before her 30th birthday.

A Phase III clinical trial at Hollings will deliver chemotherapy directly to the pancreas via a catheter, targeting the cancer at its source.

Janet Smith credits her primary care provider for catching her cancer early and encourages others to keep up with regular checkups and preventive measures.

Hollings researchers discover a way to reduce graft-versus-host disease while maintaining T-cells' ability to kill leukemia cells.

Hollings researchers find a new way to generate T-cells faster, making immediate treatment with this therapy possible.

MUSC Hollings Cancer Center researchers collaborate across disciplines to improve breast cancer prevention measures, diagnostic tools, and treatment options.

Breast cancer survivor Suzette Bussey lives out her "Be Bold" theme as she navigates cancer treatment alongside her life and career.

An MUSC Hollings Cancer Center Phase II clinical trial will examine the safety and efficacy of a new combination of drugs for treating a rare form of lymphoma.

The LOWVELO College Cup is an opportunity for MUSC students, faculty, and staff to show off their college’s dedication to funding lifesaving cancer research.

Hollings researchers discover a new biomarker whose activity can be blocked to prevent graft-versus-host disease following stem cell transplantation.

Determined to fight her metastatic breast cancer every step of the way, Jennifer Attisano gets all the enjoyment out of life that she can.

The key to curing breast cancer is catching it early, which can be difficult in women who have a type of tissue called dense breasts.

Hollings researcher Dr. Nancy Klauber-DeMore played a vital role in the FDA granting rare pediatric disease designation for a new osteosarcoma treatment.

Hollings researchers work to understand and target the barriers that lead to treatment delays in head and neck cancer patients.

Dr. Chanita Hughes-Halbert took part in the virtual congressional briefing that unveiled a first-of-its-kind cancer disparities report to the nation.

Dr. Denis Guttridge shares lessons learned from turning the 2020 Cancer Cachexia Conference into a virtual event.

The latest HPV vaccination survey shows that South Carolina's rates are on par with overall national rates for the first time.

Peggi Angel, Ph.D., received a $3 million National Cancer Institute grant to study the role of collagen in breast cancer health disparities.

Chadwick Boseman’s death at age 43 from colon cancer is a reminder of the importance of screening.

MUSC Health Blood and Marrow Transplant Program ranks in 10% of transplant centers that have exceeded predicted survival rates.

A new fleet of MUSC-developed technologies enables patients across the state to participate in smoking cessation and other clinical trials remotely.

An interdisciplinary MUSC team has identified a critical player in resistance to targeted therapy in lung cancer.

Dr. Jezabel R. Blanco received a prestigious $300,000 research award from the Rally Foundation to support her work on pediatric brain cancer.

Cancer survivor and MUSC Hollings Cancer Center LOWVELO graduate fellow Timmy Samec has committed to riding 1,700 miles in this year's LOWVELO virtual event.

MUSC researchers found almost half of people between 12 and 17 who vape have thought seriously about quitting.

Along with AstraZeneca and IQVIA, MUSC was selected be part of a Phase III trial of a vaccine that has shown promise in battling COVID-19.

As Raymond DuBois, M.D., Ph.D., begins his role as director of MUSC Hollings Cancer Center, he discusses his career path and vision for Hollings' future.

Lucy Boyce, LOWVELO's farthest away participant, can be found halibut fishing, hiking and navigating life in the wilds of Alaska.

A database created by MUSC investigators is a resource for researchers to develop a deeper understanding of breast cancer cell lines and potential therapies.

Despite a desire for normalcy, cancer patients must continue to stay vigilant about following health guidelines as the pandemic drags on.

Amid a trying time for hospitals everywhere, MUSC Health gets national recognition in new rankings.

LOWVELO returns as a virtual event for its second year with runners, walkers and cyclists logging miles to raise money for lifesaving cancer research.

LOWVELO rider Nan Robinson didn't take up cycling until later in life, but she quickly got hooked and lost 60 pounds in a year.

Hollings Cancer Center researcher Jessica Thaxton, Ph.D., received two grants to further her work on the stress that immune cells face when fighting tumors.

A new volume of cancer health equity research coedited by Hollings Cancer Center’s Marvella Ford, Ph.D., identifies potential solutions to address disparities.

Donna Rosa, a five-time cancer survivor, details how faith, family support, and doctors at Hollings Cancer Center helped her survive cancer.

With a huge increase in biking during the pandemic, bike shops have played a key role in helping people stay active and healthy.

HCC researchers published a study showing an increased risk of breast cancer in women who ate a diet high in processed foods.

Two studies highlight the importance of chronic disease prevention and management to help reduce the impact of health disparities.

HCC researchers are launching a clinical trial to study a new treatment combination for pancreatic cancer.

The latest data from a multinational research consortium shows that cancer patients face greater negative impacts from COVID-19.

Hollings Cancer Center researchers have developed a technique that could help lead to improved cancer killing ability in T cells.

Hollings Cancer Center awarded funding to five scientists as part of its fellowship program to train the next generation of cancer researchers.

Timmy Samec, a cancer researcher and patient, is the first LOWVELO graduate fellow at Hollings Cancer Center.

Originally planning to summit Mount Everest this month, Cokie Berenyi is determined COVID-19 won’t derail her from supporting MUSC Hollings Cancer Center.

Oncology nurses are celebrated during May's Oncology Nursing Month for their hard work, dedication and compassionate care.

Hollings Cancer Center researchers have developed nomogram prediction tools to help improve head and neck cancer care delivery and patient outcomes.

Researchers at Hollings Cancer Center are developing a clinical trial involving the use of T cells, normally a part of cancer treatment, to fight COVID-19.

A startup company formed by Hollings Cancer Center researchers has been awarded a grant to advance its novel adoptive cell therapy technology.

With scientists working to develop a COVID-19 vaccine, cancer researchers want the public to know about the advantages of the safe and effective HPV vaccine.

As cases of COVID-19 continue to rise across the country, African Americans have emerged as those at the highest risk for contracting the illness.

Despite all the stress COVID-19 is causing, it is especially important for smokers to try and quit the habit.

Shikhar Mehrotra, Ph.D., and Sophie Paczesny, M.D., Ph.D., named new co-leaders of the Cancer Immunology program at Hollings Cancer Center.

The COVID-19 pandemic is reshaping daily life and health care delivery for cancer patients and caregivers.

Oncologist Antonio Giordano, M.D., Ph.D., shares tips for cancer patients and their caregivers to navigate treatment during the COVID-19 pandemic.

Researchers are testing new strategies to improve head and neck cancer patient survival and decrease racial disparities in outcomes.

From the FBI down to the local level, internet security experts across the board are on the lookout for cybercriminals taking advantage of the pandemic.

MUSC study shows that the natural product derived from IndoPacific marine sponges has anticancer properties

Study involving MUSC researcher finds that states participating in Medicaid expansion are seeing more timely diagnoses for head and neck cancers.

Miranda Brown received a colon cancer diagnosis right before her wedding, but a successful combination of chemotherapy and surgery has her loving married life.

With colorectal cancers increasing in young people, knowing the symptoms and following screening recommendations are important for prevention and treatment.

Wendy Balliet, Ph.D., offers her top 12 tips to help cancer patients and caregivers find healthy ways of coping with stress due to COVID-19.

An innovative program uses parent ambassadors to help raise HPV vaccination rates.

The Big Reveal Party for LOWVELO at Hollings Cancer Center celebrated raising nearly $1 million for cancer research.

Father goes bald for a foundation to help end pediatric cancer.

Veteran and engineer shares battle with prostate cancer.

The potential mechanism of how blood clotting contributes to cancer growth has been discovered.

Study participants want to know trial results, and researchers want to tell them but lack lay communication skills.

Local mom set to summit Mount Everest to raise funds for Hollings Cancer Center.

MUSC researcher stubbs out one misconception about the effect of low-nicotine cigarettes.

A signature fundraising event for Hollings Cancer Center raised a record-breaking amount.

An MUSC researcher looks into using artificial intelligence to help rural patients and their doctors assess hereditary cancer risks.

Shedding light on a decades-old controversy, scientists found that autophagy or “self-eating” genes work against tumors in certain types of ovarian cancer.

An MUSC researcher found giving smokers a free starter kit of nicotine replacement therapy at their annual doctor visit increased their odds of quitting.

The City of Charleston and MUSC have embarked on a single-use plastic ban this year in a move toward making a healthier community and environment.

Quitting smoking can be tough, but the benefits make it well worth the effort.

As Dr. Gustavo Leone steps down as director of MUSC's Hollings Cancer Center, Denis Guttridge, Ph.D., assumes interim role to ensure smooth transition.

Two years after being told she had two weeks to live, cervical cancer survivor educates others.

Hollings Cancer Center names a new associate director of Basic Science.

Researchers tackle liver cancer in multiple ways, including the possible development of a biomarker.

As Congressman John Lewis and "Jeopardy" host Alex Trebek battle pancreatic cancer, an MUSC Health specialist discusses what’s sometimes called a silent killer.

Cancer patient finds fitness goal boosts recovery.

Writer Bryce Donovan (aka "The Grinch") tagged along with pet therapy volunteers for MUSC's annual Pet Therapy Parade.

Top tips not to miss for cancer patients and their caregivers during the holidays

Five-time NBA champ Magic Johnson paid a visit to MUSC to visit with employees as well as make the day of several young patients.

Researchers report that a novel drug combination reduced tumor volume four-fold more than chemotherapy in an animal model of triple negative breast cancer.

Hollings researchers have received funding from the NCI to support three new research projects under SC CADRE.

MUSC Health now owns the first robotic bronchoscopy machine in South Carolina, able to safely diagnose small lung cancer nodules.

$5.3 million National Cancer Institute (NCI) grant allows Hollings Cancer Center to be able to enroll more cancer patients into clinical trials.

Strength in numbers was a big theme of the ride, which was billed as a ride – not a race. It was a way for people to come together and bond over one cause.

MUSC rolls out new cost-saving methods for the university’s power that are not only good for Mother Earth but the bottom line as well.

MUSC researchers report in Science Advances that the protein, P17/PERMIT, could prove to be a connection between neurodegeneration and cancer.

MUSC Hollings Cancer Center researcher Dr. Jessica Thaxton was on winning team at renowned immunotherapy event.

MUSC researchers report in Nature Communications they have obtained 3D structural snapshots of Cdc34 in action.

What is IQOS, how does it work – and how does it compare to vaping and traditional cigarettes?

Nick Charalambous thought he had experienced the worst when a 2013 bicycle accident left him with a broken back and a broken neck.

The Point, a women’s non-profit organization, provides financial and volunteer support to the community, including Hollings Cancer Center breast cancer patients

Breast cancer patient fights cancer while pregnant, raises awareness for research and prevention.

Much like her parents, MUSC Health surgeon and researcher Heather Evans, M.D., is an overachiever.

Take a first-hand look through the eyes of one of the our reporters who rode out the storm at MUSC during Hurricane Dorian.

Doctors say vaping leads to serious lung injury in the Charleston area.

One death and dozens of hospitalizations have been linked to vaping. But wait, isn't vaping better than smoking?

Clemson head coach Dabo Swinney did a public service announcement for LOWVELO, an outdoor bike ride to fund breakthrough cancer research.

Dr. Joseph Jenrette will retire from the only career he has known – 36 years as a radiation oncologist at Hollings Cancer Center.

An innovative new program rolling out this month from MUSC Health provides in-house primary care services to patients at Hollings Cancer Center.

This couple’s amazing love story has them riding tandem in LOWVELO. And get this – one of them is just learning to ride a bike.

If there’s one life lesson Cokie Berenyi has learned, it’s that mountains can lie. “I look up at the summit, and my brain and heart tell me, ‘No way!’"

Cachexia research advances to better target debilitating effects of cancer-related wasting syndrome.

The Blue Dogs will headline the opening ceremony Nov. 1 at LOWVELO, an outdoor bike ride that raises money for cancer research at MUSC Hollings Cancer Center.

For the fifth year in a row, U.S. News and World Report has named MUSC Health the top hospital in the state in its “Best Hospitals” rankings.

Hollings Cancer Center patient receives hypothermic intraperitoneal chemotherapy treatment.

Hollings Cancer Center clinical scholar researches novel triple-negative breast cancer treatments.

Hollings Cancer Center at the Medical University of South Carolina recently announced six awardees for funding.

Thom Schmenk survives sarcoma with the help of the team from Hollings Cancer Center.

Dr. Raymond DuBois and colleagues link high-fat diet to molecular changes that can cause colorectal cancer to spread.

When she began her leadership, Tricia Bentz inherited a new program that recognized physicians for their time and effort participating in clinical research.

Researchers at MUSC Hollings Cancer Center publish their findings on how a natural antioxidant help improve immune-based therapies by modulating T-cells.

For Ben Hagood, cancer had an unexpected bright side – it led him to finding a life-long best friend in a college student 40 years younger than him.

Innovative treatments change lives. Ken Drachman should know – a clinical trial changed his.

An MUSC Health doctor is “ecstatic” about federal recommendation to bump up age range for HPV vaccination.

Electronic cigarettes have become commonplace. Now, a study shows they’re increasingly making their way into the hands of nonsmoking adolescents.

The NCI awards a $3M grant to the Hollings Cancer Center researchers to continue work on an immunotherapy combination to treat lung cancer.

South Carolina had the third largest increase in HPV up to date vaccination status from 2016 to 2017.

Good wishes from friends and strangers come to Freddie Taylor at MUSC Children’s Health, where he turns 3 on June 14.

At the inaugural LOWVELO bike ride Nov. 1-2 in Charleston riders will get to sample some of the most scenic spots in the Lowcountry.

Hollings Cancer Center researchers probed deeper into how cell division cycles are regulated.

MUSC first lady Kathy Cole was intrigued when she heard about LOWVELO, a bike ride where 100 percent of money raised will go to fund cancer research.

Dr. Michelle Hudspeth is named the new medical director of the award-winning BMT program at the MUSC Hollings Cancer Center.

T-VEC, also known as talimogene laherparepvec, is a type of oncolytic virus therapy.

MUSC researchers exploit a metabolic Achilles heel in esophageal cancer to identify potential new therapy.

MUSC researchers use natural language processing, a type of artificial intelligence, to identify socially isolated patients.

Hollings Cancer Center joins local and state leaders to celebrate the renewal of its designation as a National Cancer Institute (NCI) Cancer Center.

Diving into the details: A lipid-binding pocket is a target for new cancer therapies

Receiving a standing ovation after sharing her story, Madelene Lewis, M.D. got hugs from many attending the Linda Floyd Forum on Women’s Cancers.

Dr. Carol Sherman and Rick Hunt's doctor-patient relationship has been 19 years in the making.

Team spirit is one reason that cancer survivor Sara Dalcher participates in the Dragon Boat Charleston Festival each May.

Hollings Cancer Center announces five fellowship awardees.

3D technology gives head and neck cancer patients a chance for the quality of life they had before diagnosis.

Hollings Cancer Center bears stamp of Senator Hollings’ amazing legacy.

A study released today in JAMA Network Open reported that smoking after a cancer diagnosis is associated with substantial additional costs of cancer treatment.

Time was of the essence for Eric Mason and the girlfriend who stood by him through cancer treatment and beyond.

Hollings Cancer Center awarded seven researchers funding as part of its Pre-Clinical & Clinical Concept Award program and its Clinical Scholar program.

MUSC Health professionals attend 2019 TCT conference

The story of GARP: A potential target for cancer immunotherapy.

Hollings researcher receives funding to harness power of imaging

A volunteer at Hollings Cancer Center shows cancer patients and caregivers how to tap into the healing powers of art.

Dean Raymond DuBois to receive Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research.

Cancer centers design strategies for including more racial and ethnic minorities in clinical trials

Short radio spots on stations popular with black audiences effectively delivered culturally competent health information about chronic diseases to black men.

Hollings Cancer Center recently announced four funding awards, two as part of its Fellowship Program and two as part of its Clinical Scholar Program.

Researchers reveal a novel binding site for a class of anti-cancer drugs using X-ray crystallography.

Hollings Cancer researchers have discovered cell membrane complexes called ceramidosomes that may be a new target for drugs to kill cancer cells.

The 11th Annual Gourmet & Grapes raised a record-breaking $770,000, bringing the event’s grand total to $3.5 million raised for cancer care and research.

Lowvelo bike ride is a bold idea to pull the community together to raise funds for cancer research.

It was odd to be one of the first patients to receive a new treatment for prostate cancer, but Henry Ham was grateful to receive it.

Pediatricians want the government to get a lot tougher when it comes to vaping regulations for young people.

Graft-vs-host disease (GVHD) is a major complication of bone marrow transplant, a potentially curative therapy for blood-borne cancers.

Stacey Warneke, winner of the 2019 Excellence in Blood & Marrow Transplantation Award, will be the first to say just how amazing her patients are.

Hollings Cancer Center will roll out new mind-body class for patients and survivors to enhance health.

MUSC is one of only 8 sites across the country testing robotic lung cancer procedure.

Advanced glycation end products could help us understand cancer risk.

In a given year, more than 40 percent of smokers make no attempt to quit. For those who do, it can take many tries.

The lecture, “Vaping, Juuling and drugs” at a private Charleston school, couldn’t have been timelier.

Hollings Cancer Center researchers explore how to enhance adoptive cell transfer.

Hollings Cancer Centers researchers probe interventions that can help smokers quit.

Blood & Marrow Transplant Program at the Medical University of South Carolina receives the Team of Year award.

Veteran Joe Coen, who has stage 4 metastatic stomach cancer, gets immunotherapy at Hollings Cancer Center.

HCC researchers uncover clues to better outcomes and pinpoint health disparity issues

Hollings Cancer Center researchers say a new compound enhances a treatment for multiple myeloma in preclinical models.

A clinical trial using DFMO to prevent relapse in children with High Risk Neuroblastoma gets good results..

Chanita Hughes-Halbert receives AACR Distinguished Lecture on the Science of Cancer Health Disparities.

Event to raise money for glioblastoma research, honor achievements of man known as father of the Cooper River Bridge Run.

A team of Hollings Cancer Center gets $1.2 million grant to test antibody that could block breast cancer growth with fewer side effects.

Cyclist George Hincapie is coming to Hollings Cancer Center on Nov. 11 to lead the Jerry Zucker Ride for Hope.

In studying breast cancer, researchers keep open minds that lead to surprising find.

Study on value of second opinion for breast cancer patients found review by a tumor board changed diagnosis for 43 percent of patients.

Leukogene Therapeutics receives funding to develop compound for resistant multiple myeloma.

Scientists at Hollings Cancer Center found that some cells can divide without a molecule that was previously thought necessary.

Research details functional breakdowns that lead to cancer, point to therapeutic possibilities.

Balloons decked hallways at Hollings Cancer Center as the word spread that MUSC Health was named one of nation’s top hospitals in the treatment of cancer.

Researchers at the Medical University of South Carolina and Ohio State University say normal breast cells can prevent successful radiation treatment.

MSTP student David Hartmann wins Lasker Essay Contest, writing about campaign to let patients to describe how biomedical research improved their lives.

Hidden Scar surgery provides a woman the opportunity to preserve the natural look of her breast without a visible scars.

Scientists at Hollings Cancer Center have found a link between cancer and aging inside our cells.

MUSC Health patients are part of a national study using a virus to try to beat back recurrent glioblastomas.

International trial leads to big change in treatment for some women with breast cancer.

Hollings Cancer Center has partnered with 69 other cancer centers to issue a statement urging increased HPV vaccination and screening.

Players, family and friends support local breast cancer survivors with annual tennis tournament.

While the tumor-killing effects of chemotherapy are critical in treatment, at times there are damaging effects to healthy tissues, including bone marrow.

A Hollings Cancer Center team landed the top prize with the entry “Capturing the Sixth Vital Sign” during the shark-tank style event.

Four oncology nurses were presented Unit Nurse of the Year awards for cancer care.

Being six months pregnant in Charleston in July can be trying. Heather had resigned herself to the heat. What she hadn’t counted on was the cancer diagnosis.

Intramural funding and pilot awards support students and faculty at Hollings Cancer Center.

Actor and stand-up comedian David Lee Nelson turns his cancer diagnosis into a solo performance.

Immunotherapy at Hollings Cancer Center helped make it possible for Kerry Hardy to be the best man at his son’s wedding.

Lung cancer researchers at Hollings Cancer Center test accuracy of blood test that measures the levels of two proteins.

HCC expert provides insight to addressing cancer health disparities at annual conference.

Breast cancer survivor Tanya Waring-Hearn takes part in Cooper River Bridge Run.

Results from a clinical trial to treat lung cancer show an immunotherapy combination is surprisingly effective at controlling the disease’s progression.

Matthew Carpenter is both fascinated and concerned. The tobacco and nicotine researcher is holding a Juul.

Study shows starting screening at age 40 can diagnose about 20 percent more cancers,

Hollings Cancer Center awarded seven cancer scientists funding as part of its Fellowship Program.

Colorectal cancer is on the rise in younger adults. A survivor shares her story.

23andMe calls FDA approval of its test a milestone. One cancer expert says buyer beware

Carsten Krieg, Ph.D., and other cancer researchers hope to advance the field of immunotherapy.

Denis C. Guttridge to serve as director of Darby Children’s Research Institute, associate director of translational sciences for Hollings Cancer Center

For smokers considered at risk of developing lung cancer, a new technology-based clinical trial may help them quit once and for all.

Judith Green continues the legacy of her husband, finds joy in advocating for cancer causes.

Deborah Giles quits smoking with help from MUSC Health Tobacco Treatment Program.

Here are tips from experts at Hollings Cancer Center to help you quit smoking.

Gourmet and Grapes celebrates 10-year anniversary with fundraiser to support MUSC Hollings Cancer Center.

A clinical trial will study whether dietary and exercise interventions can decrease advanced glycation end products that have been linked to cancer

Recent study shows e-cigarettes may help reduce smoking and increase quit attempts

An innovative study looking at hair loss in a preclinical model reveals clues to how cancer spreads in a recent issue of Science Signaling.

Breakthrough discovery finds that T cells with a protein called CD26 on their surface have the best cancer-fighting potential.

Cigarette makers publish corrective statements about risks of smoking.

Researchers create powerful cancer fighters in the lab that could one day be used to treat patients.

Researcher explores link of people's AGE levels to risks for cancer and other diseases

Cancer surgeon and researcher Nancy DeMore leads trial using frankincense to try to treat breast and colon cancer.

Research may help explain how certain breast and lung cancers grow and spread

MUSC Health only hospital in state to achieve national ranking by U.S. News & World Report

The FDA could OK the use of the “living drug” approach for kids and young adults with B-cell acute lymphoblastic leukemia who haven't responded to treatment

Two surgeons joined forces to do the robotically-assisted DIEP flap surgery in what is one of the first procedures of its kind in the nation.

MUSC Hollings Cancer Center patient Hannah Neimy wrote this reflection in anticipation of National Cancer Survivors Day

Scrambler uses electrical stimulation on the skin to scramble what nerves are trying to tell the brain, to replace messages of pain with normal messages.

The potential applications of resident memory T cells for adoptive immunotherapy are not limited to melanoma.

While performing a lumpectomy, Nancy DeMore asked herself why there wasn’t an easier way to do the procedure that wouldn’t involve two invasive procedures.

Reducing the appeal and addictiveness of tobacco products would go a long way towards speeding up an end to the tobacco problem

Raymond DuBois is well known as dean of the College of Medicine at MUSC, but not everyone knows the strong advocacy work he does in the fight against cancer.

Individual differences in brain biology could be the reason some people have a harder time quitting smoking.

Noted liver cancer researcher joins Hollings Cancer Center

Higher socioeconomic status is associated with lower ovarian cancer risk in African-American women, according to MUSC study.

Immunotherapy causes paradigm shift in cancer treatment

Tiny packages may pack powerful treatment for brain tumors

Lung cancer risk reduced by pairing smoking cessation services with screenings at MUSC.

Cutting edge PET CT scanner first of its kind in US

The Hope Unit sits on the top floor of MUSC’s Ashley River Tower, with 42 beds for cancer patients.